Holen Sie sich die Stockscreener-App
30.07
1.57%
-0.48
Handel nachbörslich:
29.50
-0.57
-1.90%
Schlusskurs vom Vortag:
$30.55
Offen:
$30.77
24-Stunden-Volumen:
796.66K
Relative Volume:
0.79
Marktkapitalisierung:
$1.73B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-100.44M
KGV:
-13.55
EPS:
-2.22
Netto-Cashflow:
$-105.32M
1W Leistung:
+10.23%
1M Leistung:
+43.94%
6M Leistung:
+99.80%
1J Leistung:
-22.62%
1-Tages-Spanne:
$29.38
$30.93
1-Wochen-Bereich:
$27.45
$30.93
52-Wochen-Spanne:
$13.22
$42.57
Structure Therapeutics Inc Adr Stock (GPCR) Company Profile
Firmenname
Structure Therapeutics Inc Adr
Sektor
Branche
Telefon
(628) 229-9277
Adresse
611 GATEWAY BLVD SUITE 223, SOUTH SAN FRANCISCO
Vergleichen Sie GPCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GPCR
Structure Therapeutics Inc Adr
|
30.07 | 1.76B | 0 | -100.44M | -105.32M | -2.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Structure Therapeutics Inc Adr Stock (GPCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-02 | Eingeleitet | Citigroup | Buy |
| 2025-02-28 | Eingeleitet | William Blair | Outperform |
| 2025-01-08 | Eingeleitet | Stifel | Buy |
| 2024-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-23 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-05-21 | Eingeleitet | JP Morgan | Overweight |
| 2024-04-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-19 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-07-27 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-25 | Fortgesetzt | Jefferies | Buy |
| 2023-02-28 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-28 | Eingeleitet | Guggenheim | Buy |
| 2023-02-28 | Eingeleitet | Jefferies | Buy |
| 2023-02-28 | Eingeleitet | SVB Securities | Outperform |
Alle ansehen
Structure Therapeutics Inc Adr Aktie (GPCR) Neueste Nachrichten
Structure Therapeutics' (GPCR) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Structure Therapeutics Inc. Sponsored ADR $GPCR Shares Purchased by Signaturefd LLC - Defense World
Piper Sandler Keeps Their Buy Rating on Structure Therapeutics, Inc. Sponsored ADR (GPCR) - The Globe and Mail
Layoff Tracker: CSL Vifor, Bolt Cut Staff - BioSpace
Citius Oncology (NASDAQ:CTOR) and Structure Therapeutics (NASDAQ:GPCR) Head to Head Survey - Defense World
Structure Therapeutics (NASDAQ:GPCR) Trading Down 4.3%Should You Sell? - MarketBeat
ABSSSI Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Glenmark Pharma, Melinta Therapeutics, Sandoz Inc, Paratek Pharma, AbbVie Inc., Allergan PLC, Merck & Co. Inc., Pfizer - The Globe and Mail
ABSSSI Market to Reach New Heights in Growth by 2034, - openPR.com
Structure Therapeutics (NASDAQ:GPCR) Trading 5.8% HigherTime to Buy? - MarketBeat
Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on AI-Powered Therapeutics and Biodefense - The Globe and Mail
Banque Pictet & Cie SA Sells 11,365 Shares of Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat
Oric Pharmaceuticals (ORIC) Receives a Buy from Cantor Fitzgerald - The Globe and Mail
Structure Therapeutics stock rating reiterated at Buy by H.C. Wainwright - Investing.com India
Interactive Brokers Group, Inc. $IBKR Shares Acquired by Swedbank AB - Defense World
Sumitomo Mitsui DS Asset Management Company Ltd Makes New Investment in Confluent, Inc. $CFLT - Defense World
Exchange Traded Concepts LLC Buys 1,054 Shares of TKO Group Holdings, Inc. $TKO - Defense World
IFM Investors Pty Ltd Has $3.42 Million Stock Position in Annaly Capital Management Inc $NLY - Defense World
MongoDB, Inc. $MDB Shares Acquired by IFM Investors Pty Ltd - Defense World
Wealth Enhancement Advisory Services LLC Grows Stock Holdings in VanEck Semiconductor ETF $SMH - Defense World
Voya Investment Management LLC Buys 1,696 Shares of PriceSmart, Inc. $PSMT - Defense World
Voya Investment Management LLC Lowers Stock Position in Dutch Bros Inc. $BROS - Defense World
Vanguard Total International Bond ETF $BNDX Shares Bought by Exchange Traded Concepts LLC - Defense World
IFM Investors Pty Ltd Boosts Position in Evergy Inc. $EVRG - Defense World
IFM Investors Pty Ltd Grows Holdings in Trimble Inc. $TRMB - Defense World
UnitedHealth Group Incorporated $UNH Shares Acquired by Exchange Traded Concepts LLC - Defense World
DNOW Inc. $DNOW Shares Purchased by Exchange Traded Concepts LLC - Defense World
Exchange Traded Concepts LLC Purchases 22,809 Shares of Structure Therapeutics Inc. Sponsored ADR $GPCR - Defense World
IFM Investors Pty Ltd Purchases 2,676 Shares of Deckers Outdoor Corporation $DECK - Defense World
Exchange Traded Concepts LLC Has $1.14 Million Holdings in Molina Healthcare, Inc $MOH - Defense World
Exchange Traded Concepts LLC Acquires New Holdings in Vanguard Total Stock Market ETF $VTI - Defense World
Pallas Capital Advisors LLC Buys New Shares in Keysight Technologies Inc. $KEYS - Defense World
Parallel Advisors LLC Takes $171,000 Position in Structure Therapeutics Inc. Sponsored ADR $GPCR - Defense World
BICO Group AB (publ) (OTCMKTS:CLLKF) Stock Price Down 10.2% – Should You Sell? - Defense World
Structure Therapeutics (NASDAQ:GPCR) Shares Gap UpShould You Buy? - MarketBeat
Biotech Stocks Moving Premarket: QLGN, MBX, HSDT, And Other Gainers & Losers - RTTNews
iShares U.S. Insurance ETF $IAK Shares Sold by Focus Financial Network Inc. - Defense World
xFOREST Therapeutics and Axcelead DDP Launch Joint Research Initiative on RNA Structure-Targeted Small Molecule Drug Discovery - BioSpace
Structure Therapeutics Inc. (GPCR) Eyes Major 2025 Catalyst With Phase 2b Obesity Data - Insider Monkey
Relay Therapeutics, Inc. (RLAY) Shows Breakthrough Breast Cancer Results With RLY-2608 - Yahoo Finance
Structure Therapeutics (NASDAQ:GPCR) Trading 6.3% HigherHere's What Happened - MarketBeat
Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Receives $75.71 Average Price Target from Brokerages - MarketBeat
Analysts Are Bullish on These Healthcare Stocks: Scholar Rock Holding (SRRK), Akero Therapeutics (AKRO) - The Globe and Mail
Top 10 AI-Powered Biotech Stocks to Buy Now - Insider Monkey
Promising Market Potential for Structure Therapeutics: Buy Rating Backed by Superior Trial Results and Market Opportunities - TipRanks
Structure Therapeutics stock rating reiterated by Cantor Fitzgerald - Investing.com
Structure Therapeutics stock rating reiterated by JMP, citing positive safety data - Investing.com
Structure Therapeutics, Inc. Sponsored ADR (GPCR) Gets a Buy from LifeSci Capital - The Globe and Mail
Zimmer Partners LP Purchases 43,876 Shares of Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat
Exome Asset Management LLC Decreases Position in Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat
Equities Analysts Set Expectations for GPCR Q3 Earnings - MarketBeat
Cubist Systematic Strategies LLC Has $949,000 Stock Position in Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat
Finanzdaten der Structure Therapeutics Inc Adr-Aktie (GPCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):